Question about Market Share for the Board Since
Post# of 9122
Posted On: 04/16/2015 6:45:10 PM
Question about Market Share for the Board
Since the board appears to be in a comatose state, I'll try to inject some life here. Maybe we can discuss how small companies with disruptive technologies succeed in capturing market share despite resistance by the larger companies dominating the sector.
I'm very disappointed, for example, that we don't seem to have captured much of ther GBS diagnostic market despite the stellar testing results of 2 years ago and journal articles to back it up. Why no major announcements about deals with the Faros' employer--The Texas Health Center. And what happened to Battelle? They do have a history of entering into commercial partnerships with small companies.
Why no journal articles on the N-Assay results by Faro from almost a year ago. Wouldn't such pubs help legitimize the technology?
How does a small company with no sales staff other than a Sales Director break into this sector? Are we talking about another 5-10 years of hopeful watching? How did small companies like Xerox and Microsoft make their big moves?
One lesson I have learned from this venture is to be very leery about a company that constantly claims its lack of success is due to unfair competition by the Biggies, as well as a manipulation of its stock price. Isn't every small company trying to disrupt the Biggies faced with similar problems.. And yet some make inroads and others hit the dust.
Maybe the Ebola partnership will come through with a govt grant, but who knows how long that process will take. Can anyone still make any sense of the EPA renewing a 3 yr. CRADA with NNLX for another 2 years without having published a single journal article on this water pollution diagnostic technology during a 4 yr. period.
Replies welcome
Since the board appears to be in a comatose state, I'll try to inject some life here. Maybe we can discuss how small companies with disruptive technologies succeed in capturing market share despite resistance by the larger companies dominating the sector.
I'm very disappointed, for example, that we don't seem to have captured much of ther GBS diagnostic market despite the stellar testing results of 2 years ago and journal articles to back it up. Why no major announcements about deals with the Faros' employer--The Texas Health Center. And what happened to Battelle? They do have a history of entering into commercial partnerships with small companies.
Why no journal articles on the N-Assay results by Faro from almost a year ago. Wouldn't such pubs help legitimize the technology?
How does a small company with no sales staff other than a Sales Director break into this sector? Are we talking about another 5-10 years of hopeful watching? How did small companies like Xerox and Microsoft make their big moves?
One lesson I have learned from this venture is to be very leery about a company that constantly claims its lack of success is due to unfair competition by the Biggies, as well as a manipulation of its stock price. Isn't every small company trying to disrupt the Biggies faced with similar problems.. And yet some make inroads and others hit the dust.
Maybe the Ebola partnership will come through with a govt grant, but who knows how long that process will take. Can anyone still make any sense of the EPA renewing a 3 yr. CRADA with NNLX for another 2 years without having published a single journal article on this water pollution diagnostic technology during a 4 yr. period.
Replies welcome
(0)
(0)Nanologix Inc (NNLX) Stock Research Links
Scroll down for more posts ▼